ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board

    NEXT STORY
    VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority
    PREV STORY
    Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors

    author_avatar
    NASDAQ Market News

    T2 Biosystems Announces 11 New Patents Granted in 2017

    LEXINGTON, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader ...

    author_avatar
    NASDAQ Market News

    MATEON ANNOUNCES FIRST PATIENT ENROLLED IN ARTI-19: A MULTICENTER INTERVENTIONAL STUDY OF ARTISHIELD™ AGAINST COVID-19

    author_avatar
    NASDAQ Market News